Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Screening and Treatment Program to Eliminate Hepatitis C in Egypt.
Waked I, Esmat G, Elsharkawy A, El-Serafy M, Abdel-Razek W, Ghalab R, Elshishiney G, Salah A, Abdel Megid S, Kabil K, El-Sayed MH, Dabbous H, El Shazly Y, Abo Sliman M, Abou Hashem K, Abdel Gawad S, El Nahas N, El Sobky A, El Sonbaty S, El Tabakh H, Emad E, Gemeah H, Hashem A, Hassany M, Hefnawy N, Hemida AN, Khadary A, Labib K, Mahmoud F, Mamoun S, Marei T, Mekky S, Meshref A, Othman A, Ragab O, Ramadan E, Rehan A, Saad T, Saeed R, Sharshar M, Shawky H, Shawky M, Shehata W, Soror H, Taha M, Talha M, Tealaab A, Zein M, Hashish A, Cordie A, Omar Y, Kamal E, Ammar I, AbdAlla M, El Akel W, Doss W, Zaid H. Waked I, et al. Among authors: ammar i. N Engl J Med. 2020 Mar 19;382(12):1166-1174. doi: 10.1056/NEJMsr1912628. N Engl J Med. 2020. PMID: 32187475 No abstract available.
Treatment of hepatitis C virus infection with direct-acting antivirals plus ribavirin eliminates viral RNA from peripheral blood mononuclear cells and reduces virologic relapse in diverse hepatic parenchymal changes.
Abd Alla MDA, Dawood RM, Rashed HAE, Farrag G, Ammar IAE, Mahmoud MMA, Salum GM, Altanbouly AMA, El Meguid MA, Awady MKE. Abd Alla MDA, et al. Arch Virol. 2021 Apr;166(4):1071-1081. doi: 10.1007/s00705-021-04969-4. Epub 2021 Feb 3. Arch Virol. 2021. PMID: 33533976
Pregnancy outcome of anti-HCV direct-acting antivirals: Real-life data from an Egyptian cohort.
AbdAllah M, Alboraie M, Abdel-Razek W, Hassany M, Ammar I, Kamal E, Alalfy M, Okasha A, El Akel W, Shaaban E, Elbaz T, Hefny Z, Gomaa A, El-Bendary M, El-Serafy M, Esmat G, Doss W, El-Sayed MH. AbdAllah M, et al. Among authors: ammar i. Liver Int. 2021 Jul;41(7):1494-1497. doi: 10.1111/liv.14913. Epub 2021 May 11. Liver Int. 2021. PMID: 33905164
Nationwide hepatitis C virus screening and treatment of adolescents in Egyptian schools.
Kamal E, Asem N, Hassany M, Elshishiney G, Abdel-Razek W, Said H, Abdel Hamid S, Essam T, Rehan A, Salah A, Saad T, Shawky N, Mostafa A, Omar Y, Ammar I, Saeed R, AbdAllah M, Jabbour J, Hashish A, Bastawy S, El Qareh N, Gamaleldin N, Kabil K, Doss W, El-Sayed MH, Zaid H. Kamal E, et al. Among authors: ammar i. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):658-665. doi: 10.1016/S2468-1253(21)00464-7. Epub 2022 Apr 28. Lancet Gastroenterol Hepatol. 2022. PMID: 35489364 Review.
Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease.
El-Sayed M, Elserafy M, El Raziky M, Elakel W, Saad Y, Fayad T, Korany M, Mehrez M, Salama R, Mahrous M, Zaki A, Hassany M, Ammar I, Elsaeed K, Elshazly Y, Doss W. El-Sayed M, et al. Among authors: ammar i. Arab J Gastroenterol. 2023 Feb;24(1):29-33. doi: 10.1016/j.ajg.2022.10.001. Epub 2023 Feb 20. Arab J Gastroenterol. 2023. PMID: 36813580
HCV treatment outcome depends on SNPs of IFNL3-Gene polymorphisms (rs12979860) and cirrhotic changes in liver parenchyma.
Abd Alla MDA, Dawood RM, Rashed HAE, El-Dessouky YM, AbuFarrag GA, Ammar IAE, Mahmoud MMA, Salum GM, Abu-Amer MZ, Sekeen MAEH, Heggazy MMI, Altanbouly AMA, Abd El-Meguid M, El Awady MK. Abd Alla MDA, et al. Among authors: ammar iae. Heliyon. 2023 Oct 19;9(11):e21194. doi: 10.1016/j.heliyon.2023.e21194. eCollection 2023 Nov. Heliyon. 2023. PMID: 37928048 Free PMC article.
Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
Ben-Ammar I, Rousseau A, Nicolle R, Tarabay A, Boige V, Valery M, Pudlarz T, Malka D, Gelli M, Fernandez-De-Sevilla E, Fuerea A, Tanguy ML, Rouleau E, Barbe R, Mathieu JRR, Jaulin F, Smolenschi C, Hollebecque A, Ducreux M, Boileve A. Ben-Ammar I, et al. Eur J Cancer. 2024 Jan;197:113497. doi: 10.1016/j.ejca.2023.113497. Epub 2023 Dec 15. Eur J Cancer. 2024. PMID: 38134480
53 results